BUY Divi's Laboratories Limited — Kavita Jain, Arihant Capital Markets
byKavita Jain, Arihant Capital MarketsHorizon: NA (inferred Swing (≤2wk))11 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
2 advisors have active intraday BUY calls on this stock, all issued in the last 14 days
Advisor consensus · adjacent horizon·11 Aug · today
4 other SEBI-registered advisors have active swing BUY calls on this stock, all issued in the last 14 days
Advisor consensus · same horizon·11 Aug · today
Divi's Laboratories posts 65% PAT surge in Q1FY27 on strong revenue growth
NewsGoogle News·6 Aug · 5d ago
Divi's Labs Q1 Results: Profit Jumps 65.5%, Revenue Up 28% - Key Numbers
NewsNdtv-Profit·1 Aug · 1w ago
Divi’s Laboratories Q1 profit surges 66% to ₹902 crore, revenue rises 28%
NewsCnbc-Tv18·1 Aug · 1w ago
Divi’s Laboratories Posts Q1 FY27 Earnings Call Transcript for Investors
NewsGoogle News·6 Aug · 5d ago
Divi's Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
NSE · Outcome of Board Meeting·1 Aug · 1w ago
Q1 results today: Divi's Labs, Muthoot Finance, APL Apollo among over 30 companies set to announce Q1 earnings
NewsLivemint·1 Aug · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.